DK1007685T3 - Overfladeeksponerede proteiner fra chlamydia pneumoniae - Google Patents

Overfladeeksponerede proteiner fra chlamydia pneumoniae

Info

Publication number
DK1007685T3
DK1007685T3 DK98928179T DK98928179T DK1007685T3 DK 1007685 T3 DK1007685 T3 DK 1007685T3 DK 98928179 T DK98928179 T DK 98928179T DK 98928179 T DK98928179 T DK 98928179T DK 1007685 T3 DK1007685 T3 DK 1007685T3
Authority
DK
Denmark
Prior art keywords
kda
proteins
chlamydia pneumoniae
pneumoniae
relates
Prior art date
Application number
DK98928179T
Other languages
Danish (da)
English (en)
Inventor
Katrine Knudsen
Svend Birkelund
Gunna Christiansen
Pedersen Anna-Sofie Hebsgaard
Per Mygind
Original Assignee
Loke Diagnostics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loke Diagnostics Aps filed Critical Loke Diagnostics Aps
Application granted granted Critical
Publication of DK1007685T3 publication Critical patent/DK1007685T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK98928179T 1997-06-23 1998-06-19 Overfladeeksponerede proteiner fra chlamydia pneumoniae DK1007685T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
EP98928179A EP1007685B1 (de) 1997-06-23 1998-06-19 Oberfläche-exponierte proteine von chlamydia pneumoniae

Publications (1)

Publication Number Publication Date
DK1007685T3 true DK1007685T3 (da) 2006-08-14

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98928179T DK1007685T3 (da) 1997-06-23 1998-06-19 Overfladeeksponerede proteiner fra chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (de)
EP (1) EP1007685B1 (de)
JP (1) JP4160640B2 (de)
CN (1) CN1249233C (de)
AT (1) ATE323164T1 (de)
AU (1) AU749382B2 (de)
BR (1) BR9810288A (de)
CA (1) CA2294651A1 (de)
DE (1) DE69834194T2 (de)
DK (1) DK1007685T3 (de)
ES (1) ES2264810T3 (de)
PT (1) PT1007685E (de)
WO (1) WO1998058953A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
EP1129202A2 (de) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia polypeptiden und entspechende dna fragmenten und anwendungen davon
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1135501A1 (de) * 1998-12-01 2001-09-26 Aventis Pasteur Limited Chlamydia antigene, dafür kodierende dna und deren verwendung
JP2002531095A (ja) * 1998-12-01 2002-09-24 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
CA2365196C (en) * 1999-03-12 2011-11-15 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2373021A1 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
NZ517952A (en) * 1999-09-20 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
WO2002002606A2 (en) * 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
WO2017192902A1 (en) * 2016-05-04 2017-11-09 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
WO2020226553A1 (en) * 2019-05-06 2020-11-12 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
EP0784059B1 (de) 1994-09-20 2009-02-11 Hitachi Chemical Co., Ltd. Polynukleotide die einen antigenes polypeptid aus chlamydia pneumoniae kodieren
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
DE69834194D1 (de) 2006-05-24
JP4160640B2 (ja) 2008-10-01
CN1261403A (zh) 2000-07-26
WO1998058953A3 (en) 1999-03-18
BR9810288A (pt) 2000-09-19
CN1249233C (zh) 2006-04-05
DE69834194T2 (de) 2007-03-29
ES2264810T3 (es) 2007-01-16
CA2294651A1 (en) 1998-12-30
AU749382B2 (en) 2002-06-27
JP2002510970A (ja) 2002-04-09
ATE323164T1 (de) 2006-04-15
WO1998058953A2 (en) 1998-12-30
EP1007685B1 (de) 2006-04-12
PT1007685E (pt) 2006-08-31
EP1007685A2 (de) 2000-06-14
AU8011998A (en) 1999-01-04
US20080226679A1 (en) 2008-09-18
US7264941B1 (en) 2007-09-04

Similar Documents

Publication Publication Date Title
DK1007685T3 (da) Overfladeeksponerede proteiner fra chlamydia pneumoniae
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
UA27788C2 (uk) Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
EP1289551A4 (de) HUMANE POLYPEPTIDE WELCHE ZUM ABSTERBEN VON ZELLEN, INSBESONDERE LYMPHOIDER TUMORZELLEN, FüHREN
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
FR2828405B1 (fr) Vaccin anti-coronavirus
NO20005608L (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2004096856A3 (en) Secreted protein family
EP0834568A3 (de) Speichel-bindendes Protein von Streptococcus pneumoniae
DE60126602D1 (de) Neue collectine
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
WO2004053117A3 (en) Serine protease
PT1651765E (pt) Novas sequências nucleotídicas e sequências de aminoácidos de photobacterium damselae, e sua utilização
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
MXPA05009954A (es) Familia de proteinas secretadas.
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2002050116A3 (en) Adhesion molecule protein
DE60124299D1 (de) Peptide aus dem b-glycoprotein des menschlichen herpesvirus-7, besonders anwendbar bei serologischen elisa-nachweisen
WO2002008393A3 (en) Serine protease from yersinia enterocolitica
WO2002046380A3 (en) Protein kinase
WO2002034901A8 (en) Protein kinase
BR0107799A (pt) Proteìna de interação de wt1 wtip
MXPA05012414A (es) Proteina secretada similar a tnf.